top of page

Gracell's founder explains his company's rationale for BCMA + CD19 in both myeloma and lupus

William Cao describes how the same product might be used for cancer and lupus, explains the idea behind FasTCAR manufacturing, and gives his thoughts on the CAR-T market in China.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page